Phase 2b study evaluating diagnostic performance of 18F-RAD101 for suspected recurrent brain metastases from solid tumors of different origins Underscores Radiopharm’s commitment to developing transformative oncology radiopharmaceuticals Radiopharm Theranostics (ASX:RAD, Nasdaq: RADX, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high…
Sarama Resources (SRR:AU) has announced Initial Exploration Program Completed at Cosmo Gold Project Download the PDF here. This post…
Continuing his administration’s push toward reducing US reliance on Chinese mineral imports, President Donald Trump has signed a new…
‘Never miss out on an opportunity like a recession’ — Jack Welch, former chairman and CEO of General Electric.…
As data breaches and cyberattacks rise, cybersecurity exchange-traded funds (ETFs) are gaining traction. The term cybersecurity originated in 1989,…
Brightstar Resources (BTR:AU) has announced RHI: Acqn of royalty over Sandstone Gold Project tenements Download the PDF here. This…
It was quite a week for the gold price. The yellow metal continued its record-breaking streak early in the…
(TheNewswire) Silver Crown Royalties Inc. ( Cboe: SCRI, OTCQX: SLCRF, BF: QS0 ) ( ‘Silver Crown’ ‘SCRi’ the ‘Corporation’…